Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Sales (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Return on Sales data on record, last reported at 2.51% in Q4 2025.

  • For Q4 2025, Return on Sales rose 1.0% year-over-year to 2.51%; the TTM value through Dec 2025 reached 0.69%, up 11.0%, while the annual FY2025 figure was 0.72%, 43.0% up from the prior year.
  • Return on Sales reached 2.51% in Q4 2025 per PTCT's latest filing, up from 0.11% in the prior quarter.
  • Across five years, Return on Sales topped out at 2.51% in Q4 2025 and bottomed at 1.09% in Q1 2021.
  • Average Return on Sales over 5 years is 0.09%, with a median of 0.52% recorded in 2023.
  • Peak YoY movement for Return on Sales: skyrocketed 316bps in 2022, then crashed -284bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.83% in 2021, then skyrocketed by 380bps to 2.33% in 2022, then tumbled by -122bps to 0.51% in 2023, then skyrocketed by 593bps to 2.5% in 2024, then grew by 1bps to 2.51% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 2.51% in Q4 2025, 0.11% in Q3 2025, and 0.4% in Q2 2025.